Connection
Lindsay Standeven to Pregnanolone
This is a "connection" page, showing publications Lindsay Standeven has written about Pregnanolone.
|
|
Connection Strength |
|
 |
|
 |
|
1.079 |
|
|
|
-
Standeven LR, Osborne LM, Betz JF, Yenokyan G, Voegtline K, Hantsoo L, Payne JL. Allopregnanolone and depression and anxiety symptoms across the peripartum: an exploratory study. Arch Womens Ment Health. 2022 04; 25(2):521-526.
Score: 0.738
-
Standeven LR, Olson E, Leistikow N, Payne JL, Osborne LM, Hantsoo L. Polycystic Ovary Syndrome, Affective Symptoms, and Neuroactive Steroids: a Focus on Allopregnanolone. Curr Psychiatry Rep. 2021 04 21; 23(6):36.
Score: 0.178
-
Osborne LM, Etyemez S, Pinna G, Alemani R, Standeven LR, Wang XQ, Payne JL. Neuroactive steroid biosynthesis during pregnancy predicts future postpartum depression: a role for the 3a and/or 3?-HSD neurosteroidogenic enzymes? Neuropsychopharmacology. 2025 May; 50(6):904-912.
Score: 0.058
-
Miller KN, Standeven L, Morrow AL, Payne JL, Epperson CN, Hantsoo L. GABAergic neuroactive steroid response to sertraline in premenstrual dysphoric disorder. Psychoneuroendocrinology. 2024 Feb; 160:106684.
Score: 0.053
-
Etyemez S, Miller KN, Voegtline KM, ?zdemir I, Standeven LR, Santovito LS, Pinna G, Payne JL, Osborne LM. Metabolites of progesterone in pregnancy: Associations with perinatal anxiety. Psychoneuroendocrinology. 2023 10; 156:106327.
Score: 0.052
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|